OTC : ALPMY

Astellas Pharma Inc.

$13.14 USD

-$0.08 (-0.61%)

Volume
21.92K
Average Volume
190.76K
Market Capitalization
$23.54B
P/E Ratio
13.20
Dividend Yield
3.63%
Price Target
Year High
$17.35
Year Low
$9.46
Day High
—
Day Low
—
Payout Ratio
$0.47
Current Ratio
$1.17

ALPMY Estimated and Actual Revenue by Quarter

ALPMY Estimated and Actual EPS by Quarter

ALPMY Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-03-31 1 90.36B 94.47B 92.69B 47.11B 49.26B 48.33B
2026-12-31 1 105.81B 110.63B 108.55B 55.17B 57.68B 56.6B
2026-09-30 2 100.29B 104.86B 102.88B 52.29B 54.67B 53.64B
2026-06-30 2 96.79B 101.2B 99.29B 50.47B 52.76B 51.77B
2026-03-31 3 90.54B 94.66B 92.87B 47.21B 49.35B 48.43B
2025-12-31 6 85.84B 99.43B 94.18B 44.76B 51.84B 49.11B
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-03-31 1 32.11B 34.02B 33.19B 218.24B 228.18B 223.88B
2026-12-31 1 98.46B 104.33B 101.79B 255.57B 267.21B 262.18B
2026-09-30 2 97.97B 103.82B 101.29B 242.23B 253.26B 248.49B
2026-06-30 2 89.09B 94.4B 92.1B 233.78B 244.42B 239.82B
2026-03-31 3 53.9B 57.11B 55.72B 218.67B 228.62B 224.32B
2025-12-31 6 79.52B 84.26B 82.21B 207.33B 240.15B 227.47B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-03-31 1 509.21B 532.38B 522.36B 1 17.86516 18.93054 18.46978
2026-12-31 1 596.31B 623.45B 611.71B 1 54.78549 58.0526 56.63962
2026-09-30 2 565.18B 590.91B 579.78B 1 54.51714 57.76824 56.36219
2026-06-30 2 545.45B 570.28B 559.54B 1 49.57204 52.52825 51.24973
2026-03-31 3 510.2B 533.43B 523.38B 1 29.99234 31.78092 31.00739
2025-12-31 6 483.74B 560.33B 530.74B 1 44.24776 46.88646 45.74526